Physician profile
Charles Webb
NPI 1811967235
$979.86
in general payments reported to CMS, 2019-2025
21 companies · $574 in 2025
The $574 reported for 2025 was more than what 84% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2022: $82.68 · 2023: $39.39 · 2024: $172 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $199.47 | 2023-2025 | Dalvance |
| Steelhead Surgical INC | $111.10 | 2019 | |
| Novo Nordisk INC | $99.75 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Dexcom, INC. | $67.08 | 2025 | Dexcom G6 Transmitter |
| Ultragenyx Pharmaceutical INC. | $66.66 | 2022 | |
| Inspire Medical Systems, INC. | $65.33 | 2025 | Inspire |
| Lilly USA, LLC | $55.69 | 2024-2025 | Mounjaro |
| Bioventus LLC | $53.98 | 2025 | Durolane |
| Astrazeneca Pharmaceuticals Lp | $38.64 | 2024-2025 | Airsupra, Breztri |
| Ferring Pharmaceuticals INC. | $26.79 | 2025 | Euflexxa |
| Abiomed | $24.58 | 2025 | |
| Innovation Technologies INC | $24.47 | 2024 | Irrisept |
| Lundbeck LLC | $18.04 | 2025 | Rexulti |
| Midsouth Orthopedics INC. | $17.57 | 2025 | |
| Exact Sciences Corporation | $17.01 | 2024 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $16.99 | 2025 | Ibsrela |
| Pfizer INC. | $16.14 | 2023 | |
| Smith+Nephew, INC. | $16.02 | 2022 | |
| Abbott Laboratories | $15.90 | 2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.57 | 2024 | Xifaxan |
| Axsome Therapeutics, INC. | $14.08 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.